• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清耐酒石酸酸性磷酸酶 5b 水平与冠心病患者冠状动脉粥样硬化的严重程度和范围相关。

Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.

机构信息

Department of Internal Medicine and Cardiology, Tama-Nagayama Hospital, Nippon Medical School.

Department of Cardiovascular Medicine, Nippon Medical School.

出版信息

J Atheroscler Thromb. 2017 Oct 1;24(10):1058-1068. doi: 10.5551/jat.39339. Epub 2017 Apr 19.

DOI:10.5551/jat.39339
PMID:28428481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5656768/
Abstract

AIMS

Tartrate-resistant acid phosphatase (TRACP)-5b and osteoprotegerin (OPG) are specific and sensitive markers of bone resorption in patients with rheumatoid arthritis (RA) and chronic kidney disease (CKD). The TRACP-5b level is associated with the severity of RA and CKD, while the OPG level is associated with the severity of coronary atherosclerosis and calcification, and can predict a poor outcome in patients with coronary artery disease (CAD). However, the impact of TRACP-5b on coronary atherosclerosis in CAD patients remains unclear.

METHODS

A total of 71 CAD patients (57 men, 14 women; mean age: 69.0±9.7 years) and 28 age- and gender- matched healthy subjects were investigated. The number of diseased vessels (a marker of the severity of coronary atherosclerosis) and the Gensini score (a marker of the extent of coronary atherosclerosis), as well as the OPG and TRACP-5b levels were measured in CAD patients. The TRACP-5b levels were classified into quartiles.

RESULTS

The TRACP-5b levels were significantly higher in CAD patients than in healthy subjects. Patients with higher TRACP-5b levels had higher OPG levels and Gensini scores than those with lower TRACP-5b levels. Higher TRACP-5b levels were associated with an increased number of diseased vessels. A multivariate linear regression analysis showed that the OPG level and the number of diseased vessels or the Gensini score were significantly and independently associated with the TRACP-5b level.

CONCLUSIONS

These data indicate that the TRACP-5b level is significantly associated with the OPG level and with the severity and extent of coronary atherosclerosis in CAD patients.

摘要

目的

抗酒石酸酸性磷酸酶 5b(TRACP-5b)和骨保护素(OPG)是类风湿关节炎(RA)和慢性肾脏病(CKD)患者骨吸收的特异性和敏感标志物。TRACP-5b 水平与 RA 和 CKD 的严重程度相关,而 OPG 水平与冠状动脉粥样硬化和钙化的严重程度相关,并可预测冠心病(CAD)患者的不良预后。然而,TRACP-5b 对 CAD 患者冠状动脉粥样硬化的影响尚不清楚。

方法

共纳入 71 例 CAD 患者(57 名男性,14 名女性;平均年龄:69.0±9.7 岁)和 28 名年龄和性别匹配的健康对照者。在 CAD 患者中测量了病变血管数量(冠状动脉粥样硬化严重程度的标志物)和 Gensini 评分(冠状动脉粥样硬化程度的标志物),以及 OPG 和 TRACP-5b 水平。TRACP-5b 水平分为四分位数。

结果

CAD 患者的 TRACP-5b 水平明显高于健康对照者。TRACP-5b 水平较高的患者的 OPG 水平和 Gensini 评分高于 TRACP-5b 水平较低的患者。较高的 TRACP-5b 水平与病变血管数量的增加相关。多元线性回归分析显示,OPG 水平和病变血管数量或 Gensini 评分与 TRACP-5b 水平显著且独立相关。

结论

这些数据表明,TRACP-5b 水平与 OPG 水平以及 CAD 患者冠状动脉粥样硬化的严重程度和程度显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15a/5656768/40ff3c1aac78/jat-24-1058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15a/5656768/e7b7ec7f837c/jat-24-1058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15a/5656768/40ff3c1aac78/jat-24-1058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15a/5656768/e7b7ec7f837c/jat-24-1058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a15a/5656768/40ff3c1aac78/jat-24-1058-g002.jpg

相似文献

1
Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.血清耐酒石酸酸性磷酸酶 5b 水平与冠心病患者冠状动脉粥样硬化的严重程度和范围相关。
J Atheroscler Thromb. 2017 Oct 1;24(10):1058-1068. doi: 10.5551/jat.39339. Epub 2017 Apr 19.
2
[Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].[透析前慢性肾脏病患者冠状动脉钙化评分与腹部钙化评分、血清骨保护素(OPG)及血清抗酒石酸酸性磷酸酶(TRACP)-5b之间的关系]
Nihon Jinzo Gakkai Shi. 2010;52(8):1022-8.
3
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.抗酒石酸酸性磷酸酶同工型5b:一种用于监测多发性骨髓瘤骨病的新型血清标志物。
Int J Cancer. 2003 Sep 1;106(3):455-7. doi: 10.1002/ijc.11247.
4
Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.使用荧光底物萘酚ASBI-磷酸盐和肝素的抗酒石酸酸性磷酸酶同工型5b替代免疫测定法
Clin Chim Acta. 2004 Sep;347(1-2):157-67. doi: 10.1016/j.cccn.2004.04.021.
5
Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.抗酒石酸酸性磷酸酶5b是类风湿关节炎的潜在生物标志物:一项针对汉族人群的初步研究
Chin Med J (Engl). 2014;127(16):2894-9.
6
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.血清骨保护素和骨桥蛋白水平与动脉僵硬度以及冠状动脉疾病的存在和严重程度相关。
Int J Cardiol. 2013 Sep 1;167(5):1924-8. doi: 10.1016/j.ijcard.2012.05.001. Epub 2012 May 27.
7
Significance of serum TRACP in rheumatoid arthritis.血清抗酒石酸酸性磷酸酶在类风湿关节炎中的意义。
J Bone Miner Res. 2008 Aug;23(8):1287-95. doi: 10.1359/jbmr.080329.
8
Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.抗酒石酸酸性磷酸酶同工型5b作为破骨细胞活性的血清标志物。
Clin Chem. 2001 Jan;47(1):74-80.
9
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.类风湿关节炎患者血清骨保护素水平升高,且与冠状动脉粥样硬化独立相关。
Atherosclerosis. 2007 Dec;195(2):e135-41. doi: 10.1016/j.atherosclerosis.2007.04.049. Epub 2007 Jun 14.
10
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.骨保护素与内皮功能相关,并可预测冠心病患者早期颈动脉粥样硬化。
Int Heart J. 2015;56(6):605-12. doi: 10.1536/ihj.15-150. Epub 2015 Nov 9.

引用本文的文献

1
Plasma proteome and incident myocardial infarction: sex-specific differences.血浆蛋白质组与心肌梗死事件:性别特异性差异。
Eur Heart J. 2024 Nov 14;45(43):4647-4657. doi: 10.1093/eurheartj/ehae658.
2
Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses.通过批量和单细胞转录组分析对非酒精性脂肪性肝病和动脉粥样硬化之间的共享风险基因及免疫代谢进行综合分析。
Heliyon. 2024 Jul 30;10(15):e35453. doi: 10.1016/j.heliyon.2024.e35453. eCollection 2024 Aug 15.
3
A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development.

本文引用的文献

1
Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence.通过皮肤自发荧光评估晚期糖基化终末产物与日本2型糖尿病患者冠状动脉钙化的相关性
J Atheroscler Thromb. 2016 Oct 1;23(10):1178-1187. doi: 10.5551/jat.30155. Epub 2016 Mar 10.
2
Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.骨保护素与内皮功能相关,并可预测冠心病患者早期颈动脉粥样硬化。
Int Heart J. 2015;56(6):605-12. doi: 10.1536/ihj.15-150. Epub 2015 Nov 9.
3
一项关于基于PAN细胞焦亡的基因在动脉粥样硬化发展中作用的初步研究。
J Inflamm Res. 2023 Dec 22;16:6283-6299. doi: 10.2147/JIR.S442260. eCollection 2023.
4
Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification.骨保护素/核因子κB受体激活剂配体参与牙周炎促进的血管钙化。
Exp Ther Med. 2022 Jun 14;24(2):512. doi: 10.3892/etm.2022.11439. eCollection 2022 Aug.
5
Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure.血清抗酒石酸酸性磷酸酶5b(TRACP5b)是一种骨吸收标志物,与住院心力衰竭患者不良心脏预后相关。
CJC Open. 2020 Dec 13;3(4):470-478. doi: 10.1016/j.cjco.2020.12.005. eCollection 2021 Apr.
6
Changes of lipid and bone metabolism in broilers with spontaneous femoral head necrosis.肉鸡自发性股骨头坏死的脂类和骨代谢变化。
Poult Sci. 2021 Mar;100(3):100808. doi: 10.1016/j.psj.2020.10.062. Epub 2020 Nov 3.
7
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI).溶血磷脂作为ST段抬高型心肌梗死(STEMI)和非ST段抬高型心肌梗死(NSTEMI)的预测标志物。
Metabolites. 2020 Dec 31;11(1):25. doi: 10.3390/metabo11010025.
8
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non-ischaemic heart failure.一项用于识别区分缺血性与非缺血性心力衰竭的病理生理途径的网络分析。
Eur J Heart Fail. 2020 May;22(5):821-833. doi: 10.1002/ejhf.1811. Epub 2020 Apr 3.
9
Intensive weight gain therapy in patients with anorexia nervosa results in improved serum tartrate-resistant acid phosphatase (TRAP) 5a and 5b isoform protein levels.神经性厌食症患者的强化体重增加疗法可使血清抗酒石酸酸性磷酸酶(TRAP)5a和5b同工型蛋白水平得到改善。
Eat Weight Disord. 2020 Oct;25(5):1387-1397. doi: 10.1007/s40519-019-00776-8. Epub 2019 Sep 17.
10
Association of circulating microRNA-122 with presence and severity of atherosclerotic lesions.循环微小RNA-122与动脉粥样硬化病变的存在及严重程度的关联
PeerJ. 2018 Jul 4;6:e5218. doi: 10.7717/peerj.5218. eCollection 2018.
Osteoprotegerin: osteo-vascular connection.
骨保护素:骨与血管的联系。
J Atheroscler Thromb. 2015;22(3):233-4. doi: 10.5551/jat.ED004. Epub 2015 Feb 6.
4
Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients.血清骨保护素与根据高血压患者的心踝血管指数评估的动脉僵硬度相关。
J Atheroscler Thromb. 2015;22(3):304-12. doi: 10.5551/jat.25882. Epub 2014 Oct 15.
5
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?骨保护素能否用于在不同临床环境中识别冠心病的存在和严重程度?
Atherosclerosis. 2014 Oct;236(2):230-6. doi: 10.1016/j.atherosclerosis.2014.07.013. Epub 2014 Jul 21.
6
Tartrate-resistant acid phosphatase 5a in sarcoidosis: further evidence for a novel macrophage biomarker in chronic inflammation.结节病中抗酒石酸酸性磷酸酶5a:慢性炎症中新型巨噬细胞生物标志物的进一步证据
J Formos Med Assoc. 2014 Jun;113(6):364-70. doi: 10.1016/j.jfma.2012.07.033. Epub 2012 Sep 1.
7
The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.急性冠状动脉综合征和稳定型心绞痛患者中骨保护素水平与冠状动脉疾病程度的关系。
Kardiol Pol. 2014;72(1):34-41. doi: 10.5603/KP.2014.0004.
8
Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.骨保护素作为肾移植受者肾脏和心血管结局的预测指标:来自ALERT研究的随访数据
Nephrol Dial Transplant. 2012 Jun;27(6):2571-5. doi: 10.1093/ndt/gfr694. Epub 2011 Dec 15.
9
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation.骨保护素/核因子-κB 受体激活剂(RANK)/RANK 配体轴在心房颤动发生和进展中的心房基因表达失调。
Circ J. 2011;75(12):2781-8. doi: 10.1253/circj.cj-11-0795. Epub 2011 Oct 15.
10
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.血浆护骨素与颈动脉和外周动脉疾病有关,但与 2 型糖尿病心肌缺血无关。
Cardiovasc Diabetol. 2011 Aug 12;10:76. doi: 10.1186/1475-2840-10-76.